SC66 is a new type of allosteric AKT inhibitor, and the chemical formula of SC66 is shown in Figure 2A. To explore the effect of SC66 on the proliferation activity of BC cells, the cell viability of T24 and 5637 cells was tested at different drug concentrations using the CCK‐8 assay. This evidence concerns the gene AKT1 and breast cancer.